These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis. Kates WR, Olszewski AK, Gnirke MH, Kikinis Z, Nelson J, Antshel KM, Fremont W, Radoeva PD, Middleton FA, Shenton ME, Coman IL. Schizophr Res; 2015 Jan; 161(1):76-84. PubMed ID: 25066496 [Abstract] [Full Text] [Related]
4. White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis. Perlstein MD, Chohan MR, Coman IL, Antshel KM, Fremont WP, Gnirke MH, Kikinis Z, Middleton FA, Radoeva PD, Shenton ME, Kates WR. Schizophr Res; 2014 Jan; 152(1):117-23. PubMed ID: 24321711 [Abstract] [Full Text] [Related]
5. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]. Demily C, Rossi M, Schneider M, Edery P, Leleu A, d'Amato T, Franck N, Eliez S. Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123 [Abstract] [Full Text] [Related]
13. Identifying neurodevelopmental anomalies of white matter microstructure associated with high risk for psychosis in 22q11.2DS. Bagautdinova J, Padula MC, Zöller D, Sandini C, Schneider M, Schaer M, Eliez S. Transl Psychiatry; 2020 Nov 24; 10(1):408. PubMed ID: 33235187 [Abstract] [Full Text] [Related]
15. Genetic contributions to changes of fiber tracts of ventral visual stream in 22q11.2 deletion syndrome. Kikinis Z, Makris N, Finn CT, Bouix S, Lucia D, Coleman MJ, Tworog-Dube E, Kikinis R, Kucherlapati R, Shenton ME, Kubicki M. Brain Imaging Behav; 2013 Sep 24; 7(3):316-25. PubMed ID: 23612843 [Abstract] [Full Text] [Related]
16. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety. Scott JA, Goodrich-Hunsaker N, Kalish K, Lee A, Hunsaker MR, Schumann CM, Carmichael OT, Simon TJ. J Psychiatry Neurosci; 2016 Apr 24; 41(3):203-13. PubMed ID: 26599134 [Abstract] [Full Text] [Related]
17. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. Schneider M, Van der Linden M, Menghetti S, Glaser B, Debbané M, Eliez S. J Psychiatr Res; 2014 Jan 24; 48(1):86-93. PubMed ID: 24189154 [Abstract] [Full Text] [Related]
18. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits. Mekori-Domachevsky E, Taler M, Shoenfeld Y, Gurevich M, Sonis P, Weisman O, Weizman A, Gothelf D. J Clin Psychiatry; 2017 Jan 24; 78(9):e1219-e1225. PubMed ID: 29141125 [Abstract] [Full Text] [Related]